DCGI approves advanced trials for Biological E. Limited’s COVID- 19 vaccine
New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator ...
Thursday, April 25, 2024
Tag: immunogenicity
First mRNA-based COVID 19 vaccine gets nod for phase II/III trial
New Delhi: The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the ...
